Advanced Risk Assessment Methods Described in New Study

BOSTON, Oct. 20, 2022 /PRNewswire/ — Improving assessment of patient risk at hospital admission guides patient care and facilitates epidemiologic analyses. New research conducted by Health Data Analytics Institute (HDAI), in collaboration with researchers at the Cleveland Clinic, is being presented as a featured abstract at the 2022 Annual meeting of the American Society of Anesthesiologists on October 22 in New Orleans and will soon be published as a feature article in Anesthesiology, the Society’s journal. The data show that predictive modeling based on administrative claims history provides individualized patient risk profiles at hospital admission that can guide patient management. The report is titled “Risk Stratification Index 3.0, a Broad Set of Models for Predicting Adverse Events During and After Hospital Admission.”

“Our goal was to deliver a suite of easily deployable models for use by hospitals and health systems. Specifically, we developed and validated a broad suite of predictive tools based only on information available to a clinician before or on the day of admission to the hospital. Using individual medical claims history and demographic information, we accurately predicted risk for many adverse events up to ninety days post admission. We also observed similar outcomes from six different popular modeling approaches, which suggests that the predictive information derived from medical claims history can be extracted utilizing a variety of modeling techniques,” said Nassib Chamoun, Founder, President, and CEO of HDAI.

Methodology: Predicted outcomes included excess length of stay, discharge status, unplanned hospital admissions, in-hospital and 90-day mortality, acute kidney injury, sepsis, pneumonia, respiratory failure, and a composite of major cardiac complications. Patient demographic and coding history in the year before admission provided features used to predict utilization and adverse events through 90-days post-admission. Models were trained and refined on 2017-18 Medicare admissions data using an 80-20 learn/test split sample. Models were then prospectively tested on 2019 out-of-sample Medicare admissions. Predictions based on logistic regression were compared with those from five commonly used machine learning methods using a separate limited dataset.

Results: The 2017-18 development set included 9,085,968 patients who had 18,899,224 inpatient admissions, and there were 5,336,265 patients who had 9,205,835 inpatient admissions in the 2019 validation dataset. Model performances on the validation set all exceeded the pre-specified acceptance criteria with an average area under the curve of 0.76 (Range 0.70, 0.82). Model calibration was very strong. Predictive accuracies from regression and machine learning techniques were generally similar.

“We are starting to deploy these tools for preoperative optimization and for developing risk-specific care paths to avoid complications.” said Kamal Maheshwari, MD, MPH, Departments of General Anesthesiology and Outcomes Research at the Cleveland Clinic and one of the study authors. “Including a nationwide sample of millions of patients increases our confidence in practical application of these models to our work with patients before, during, and after surgery”.

Health systems and Accountable Care Organizations use HDAI’s predictive analytic product, named Health Vision, to support their care teams at the population and patient level, generating over 20M predictions every week. These innovative organizations are deploying the system as a stand-alone system fed by claims data in as little as 48 hours. Some are also enhancing the immediacy of the data through real-time EHR integration.

The Health Vision platform leverages the underlying models validated in this study and enables care teams to rapidly identify patients at high risk for adverse events, along with the underlying factors that contribute to each risk. Subsequently, clinicians can leverage the patient’s curated health history, including all encounters, medications, providers, tests, diagnoses, and interventions, to generate a personalized care plan, pre- and post-hospitalization.

The complete findings of the study, funded by HDAI, can be viewed online here and will be available in print in the coming months.

About HDAI

Health Data Analytics Institute (HDAI) is an analytics company with a versatile analytic platform that creates a shared understanding of quantified health risks and personalized care profiles to inform actions with the greatest potential to benefit patients. The predictors are built on extensive underlying data assets, driven by a sophisticated risk modeling methodology, and validated in multiple peer-reviewed articles. For more information, please visit: www.hda-institute.com.

Company contact: Carola Endicott, [email protected], 617-314-6135 

SOURCE Health Data Analytics Institute

 

 

LinkedIn
Facebook
Twitter

Your privacy matters

We believe that an individual’s meaningful control over their own data is as valuable as the data itself. That’s why we are committed to protecting privacy at every turn.
We always:
  • Provide transparency about the information we collect and why we collect it
  • Comply with all applicable privacy rules and regulations
  • Delete personal data from our servers if an individual opts out
We never:
  • Sell data to third parties
  • Share data with third parties besides the primary, explicitly authorized institution
  • Collect data besides what is disclosed
  • Keep personal data for individuals who have opted out

We speak legalese only when we have to, but we do our best to keep it human. Provided below are the full versions of our Privacy Policy and Terms of Service. If you have any questions, don’t hesitate to contact us for clarification.

Bob Scott
VP Security, Compliance, and IT Operations

Bob has 20 years experience enhancing IT systems and security programs in regulated companies.  He has worked with global enterprises down to 10-person start-ups.  He currently holds both CISSP and CCSP certificates from ISC2.  Bob’s professional passion is negotiating the sweet-spot between Security, Efficiency and Company Resources.  Personally, Bob is a land-locked boatsman who laments every day away from the water and an avid table-top gamer.  He received a BS in Microbiology from Cornell.

George Pace

VP Business Development, Payer Markets

George has over two decades of consulting, business development and client success experience in health care, working with both providers and payers to address their most pressing challenges. The bulk of his healthcare career was with The Advisory Board, Optum, Premier and Verisk Health, with a focus on risk mitigation, value-based care and population health management. He is deeply passionate about helping healthcare organizations do their best for their patients and beneficiaries. 

When he’s not working, you will find him playing guitar, riding his bike or spending time with family, friends, and his dog Luna.  

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Karan (Kay) Mansukhani
VP Business Development

Kay has a decade of experience in population health analytics.  Starting his career in Maryland’s state-designated HIE – CRISP,  he was entrusted to set up the infrastructure and data elements needed by health system to achieve CMMIs Triple Aim. Kay is a trained epidemiologist who has a passion for preventive medicine, psychology, and anthropology. Kay enjoys spending lazy days with his wife Sonal, and son Avtar on the beach.  Kay also enjoys listening to podcasts, playing the guitar and badminton. He received his joint MPH MBA from Johns Hopkins University.

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray VP Analytic Services

Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.

Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain Chief Product Officer

David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.

Margie Ahearn
VP HR

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO

Nassib is a data scientist, lover of logistical regression and a serial entrepreneur. Previously, he was Founder and CEO of Aspect Medical Systems, a Nasdaq traded company now owned by Medtronic. Outside of work, he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture

1

We are driven to make a profound impact on US healthcare

2

We operate in the best interests of patients and those who serve them

3

We understand and protect patient privacy and health information security

4

We use data science to enhance, but never replace clinical expertise and judgment

5

We are committed to continuous learning and improvement

6

We bring rigor, discipline, and reliability to our work

7

We start with kindness, assuming good intent in others

8

We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated

9

We are committed to the well-being of our employees and their families

Our vision

We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, which will improve the health of individuals and populations.

Our mission

Deploy a versatile analytic platform that creates a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients.

Who we are

We collaborate with leading health systems and integrated delivery networks, value-based care and accountable care organizations, physician groups, and commercial payers to improve care delivery and population health while reducing costs and making efficient use of scarce clinical resources.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.